Bruker Invests in Atinary to Boost AI-Driven Lab Automation
Event summary
- Bruker Corporation has expanded its strategic collaboration with Atinary Technologies, including a minority investment in the AI-driven R&D company.
- Atinary will integrate Bruker’s analytical instruments and SciY scientific software into its Self-Driving Labs® platform for automated closed-loop workflows.
- A joint demonstration lab has been established at Chemspeed’s headquarters near Basel, Switzerland, with another Atinary lab in Boston focusing on small-molecule synthesis and catalysis.
The big picture
Bruker’s investment in Atinary underscores the growing trend of AI and robotics transforming traditional R&D workflows. By combining Bruker’s analytical instruments with Atinary’s Self-Driving Labs®, the collaboration aims to accelerate scientific discovery across multiple industries. This strategic move positions Bruker at the forefront of the AI-driven lab automation market, potentially setting a new standard for efficiency in pharmaceutical and materials research.
What we're watching
- Integration Success
- How effectively Bruker and Atinary can integrate their technologies to enhance AI-driven experimentation.
- Market Expansion
- Whether the collaboration will accelerate adoption of self-driving labs in pharmaceutical R&D and other industries.
- Competitive Dynamics
- The pace at which competitors respond with similar AI-driven lab automation solutions.
Related topics